市场调查报告书
商品编码
1495441
剂量监测设备市场:按类型、应用分类 - 2024-2030 年全球预测Dose Monitoring Device Market by Type (Active, Passive), Application (Computed Radiography, Fluoroscopy & Interventional Imaging, Mammography) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
剂量监测设备市场规模预估2023年为33.2亿美元,2024年达36亿美元,预估2030年将达59.2亿美元,复合年增长率为8.62%。
剂量监测设备是复杂的技术工具,旨在准确测量和追踪患者在诊断成像期间接受的辐射剂量。剂量监测设备在最大限度地减少不必要的辐射暴露、遵守放射照相中的「尽可能低」(ALARA) 原则以及确保病患安全方面发挥着重要作用。剂量监测设备可与各种影像设备(例如 CT 扫描仪、X 光机和乳房X光摄影摄影机)集成,为医护人员提供即时资料和警报。这可以优化成像通讯协定,以确保每位患者接受准确诊断所需的精确辐射剂量,同时最大限度地降低健康风险。越来越多的慢性疾病需要精准医疗,以及越来越多地采用先进的医疗技术,正在推动剂量监测设备市场的成长。然而,与现有医疗IT基础设施整合相关的技术复杂性阻碍了剂量监测设备的采用。增强与电子健康记录(EHR) 的互通性以及用于资料管理和分析的开拓SaaS(软体即服务)平台为剂量监测设备市场的成长提供了有利可图的机会。
主要市场统计 | |
---|---|
基准年[2023] | 33.2亿美元 |
预测年份 [2024] | 36亿美元 |
预测年份 [2030] | 59.2亿美元 |
复合年增长率(%) | 8.62% |
区域洞察
在美洲,特别是在美国和加拿大,不断上涨的医疗保健成本、技术进步以及对病人安全的重视正在推动剂量监测设备的创新和采用。严格的法规和患者意识提升计划进一步推动了美国对剂量监测设备的需求。加拿大剂量监测设备市场受到该国注重患者安全和用药准确性的医疗保健政策的推动。政府对医疗保健提供者采用数位医疗技术的奖励值得注意。在亚太地区,医疗保健投资的迅速增加和用药安全意识的提高正在推动对剂量监测设备的需求。由于医疗基础设施的大量投资和製药行业的蓬勃发展,中国剂量监测设备的采用率不断增加。在日本,随着人口老化和慢性病数量的增加,精准医疗的需求不断增加。这一趋势凸显了对先进剂量监测设备的迫切需求,以确保准确和个人化的治疗方法。在印度,快速的都市化和医疗改革正在推动对剂量监测设备的需求。欧盟国家透过医疗设备法规 (MDR) 等统一法规强调剂量监测设备的高品质和安全标准。由于对医疗基础设施的策略性投资和对慢性病管理的日益重视,中东地区正在经历成长。非洲剂量监测设备市场对医疗基础设施的投资不断增加,为未来的成长奠定了基础。
FPNV定位矩阵
FPNV 定位矩阵对于评估剂量监测设备市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对剂量监测设备市场供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对剂量监测设备市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[182 Pages Report] The Dose Monitoring Device Market size was estimated at USD 3.32 billion in 2023 and expected to reach USD 3.60 billion in 2024, at a CAGR 8.62% to reach USD 5.92 billion by 2030.
A dose monitoring device is an advanced technological tool designed for accurately measuring and tracking the radiation doses a patient receives during diagnostic imaging procedures. The dose monitoring devices play a crucial role in ensuring patient safety by minimizing exposure to unnecessary radiation, thereby adhering to the principle of "As Low As Reasonably Achievable" (ALARA) in radiographic practices. Dose monitoring devices can be integrated with various imaging equipment, such as CT scanners, X-ray machines, and mammography units, providing real-time data and alerts to healthcare professionals. This enables the optimization of imaging protocols, ensuring that each patient receives the precise amount of radiation required for accurate diagnosis while minimizing health risks. The rising incidences of chronic diseases requiring precision medicine and the increasing adoption of advanced healthcare technologies are driving the growth of the dose-monitoring device market. However, technical complexities associated with integration into existing healthcare IT infrastructures hinder the adoption of dose-monitoring devices. Enhancing interoperability with electronic health records (EHRs) and developing software-as-a-service (SaaS) platforms for data management and analysis offer remunerative opportunities for the growth of the dose monitoring device market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.32 billion |
Estimated Year [2024] | USD 3.60 billion |
Forecast Year [2030] | USD 5.92 billion |
CAGR (%) | 8.62% |
Regional Insights
In the Americas, especially in the United States and Canada, there has been innovation and adoption of dose monitoring devices due to high healthcare expenditure, technological advancements, and a strong emphasis on patient safety. The need for dose monitoring devices in the U.S. is further bolstered by stringent regulations and patient awareness programs. Canada's dose monitoring device market is driven by national healthcare policies focusing on patient safety and medication accuracy. Government incentives for healthcare providers to adopt digital health technologies are notable. The surge in healthcare investments and a rising awareness of medication safety propel demand for dose monitoring devices in the Asia-Pacific region. China is witnessing an increase in the adoption of dose monitoring devices with considerable investments in healthcare infrastructure and a booming pharmaceutical industry. The need for precision medicine is rising in Japan, driven by an aging population and the increasing prevalence of chronic diseases. This trend underscores the critical need for advanced dose monitoring devices to ensure accurate and individualized treatment regimens. Rapid urbanization and healthcare reform drive demand for dose monitoring devices in India. The EU countries are highlighted by their unified regulations, including the Medical Devices Regulation (MDR), which emphasizes high quality and safety standards for dose monitoring devices. The Middle East region is witnessing growth through strategic investments in healthcare infrastructure and a growing emphasis on chronic disease management. The African dose monitoring device market showcases increasing investments in healthcare infrastructure, laying the groundwork for future growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Dose Monitoring Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Dose Monitoring Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Dose Monitoring Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Dozee introduces ambulatory connected patient monitoring system Dozee Pro Ex'
Dozee introduced Dozee Pro Ex, an ambulatory-connected patient monitoring system designed in India for global usage, signifying a major leap in continuous healthcare monitoring. This advanced system is empowered with wireless wearable sensors for relentless tracking of vital signs such as ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature. Notably, it integrates an AI-enhanced early warning system that diligently analyzes vital parameter trends, offering prompt notifications of potential clinical deteriorations. This technology enables healthcare providers to efficiently monitor patients - whether in bed, moving within hospital premises, or at home - through a centralized control center and dedicated mobile applications for medical professionals. [Published On: 2023-10-06]
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
In a significant advancement for Alzheimer's disease treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval for LEQEMBI (lecanemab-irmb) 100 mg/mL injection, as announced by Eisai Co., Ltd. and Biogen Inc. This humanized monoclonal antibody, aimed at both soluble and insoluble amyloid beta formations characteristic of Alzheimer's, has shown promise in reducing the accumulation of amyloid beta plaques in the brain, a core feature of the disease. Indicated for patients with mild cognitive impairment or mild dementia stages of Alzheimer's, LEQEMBI necessitates careful patient selection and monitoring, especially for amyloid-related imaging abnormalities (ARIA). [Published On: 2023-01-06]
Tracerco announces launch of next generation personal electronic dosimeter range - Tracerco PED2
Tracerco introduced advancement in personal radiation safety; the PED2 dosimeters embody Tracerco's patented detection technology, propelling its legacy of excellence in active dosimetry. The PED2 series, a refined version of the acclaimed PED range, offers superior radiological safety management, especially in demanding conditions. Simon Lambert, Tracerco's Technology Manager, highlights the product's enhanced usability, management ease, and development in collaboration with seasoned users, ensuring an extraordinary market offering. [Published On: 2022-03-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Dose Monitoring Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Dose Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bracco S.p.A., Canon Inc., Dozee, Fuji Electric Co., Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guerbet, IBA Dosimetry GmbH, Infab Corporation, INFINITT Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Inc. by Fortive Corporation, Medic Vision, Medsquare, Mirion Technologies, Inc., Novarad Corporation, PACSHealth, LLC, QAELUM NV, RaySafe by Fluke Corporation, Sectra AB, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and Volpara Health Limited.
Market Segmentation & Coverage